1 Einträge von mit news clotting
www.cslbehring.ch
Datum der Indexierung 04.10.2024 23:31:04
erkannte Namen Gene Therapy | Emmanuelle Lecomte | Isabelle Dahinden | Maria Tortoreto | Asia Pacific |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Swissmedic Approval for HEMGENIX®
Kombination Keywords patients rare | hemgenix this | factor from | hemophilia people | with gene | treatment disease | that therapy | behring your | bleeding more | switzerland global |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
News Health Professionals CSL Behring Switzerland Back Search Popular search terms: Careers at CSL Collaboration with CSL Our Company Our Company Leadership Group Our Story Diversity, Equity & Inclusion Bern Location Partnering Cooperation Patien clotting. “This approval is further demonstration of CSL’s promise to pursue, develop and deliver new innovative treatment options that meet the needs of the rare disease community,” said Emmanuelle Lecomte-Brisset, Senior Vice Pr
Text Inhalt Text aus URL
Log Metriken 86111
erkannte Namen Gene Therapy | Emmanuelle Lecomte | Isabelle Dahinden | Maria Tortoreto | Asia Pacific |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Swissmedic Approval for HEMGENIX®
Kombination Keywords patients rare | hemgenix this | factor from | hemophilia people | with gene | treatment disease | that therapy | behring your | bleeding more | switzerland global |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
News Health Professionals CSL Behring Switzerland Back Search Popular search terms: Careers at CSL Collaboration with CSL Our Company Our Company Leadership Group Our Story Diversity, Equity & Inclusion Bern Location Partnering Cooperation Patien clotting. “This approval is further demonstration of CSL’s promise to pursue, develop and deliver new innovative treatment options that meet the needs of the rare disease community,” said Emmanuelle Lecomte-Brisset, Senior Vice Pr
Text Inhalt Text aus URL
Log Metriken 86111